Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

63 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 16, 2026Mar 18 9:19 PMHOUGEN ELIZABETH LEVP, Finance & CFO
Sale
215,048$72.40$15.6M92,832(D)

View →

Mar 16, 2026Mar 16 8:32 PMHOUGEN ELIZABETH L
Proposed Sale
225,200$72.31$16.3M

View →

Mar 9, 2026Mar 11 8:19 PMPatrick R. O'NeilEVP CLO & General Counsel
Sale
10,148$75.25$763.7K62,211(D)

View →

Mar 10, 2026Mar 11 8:19 PMBrett P MoniaDirector, Chief Executive Officer
Sale
34,103$75.92$2.6M242,662(D)

View →

Mar 9, 2026Mar 11 8:19 PMBrett P MoniaDirector, Chief Executive Officer
Sale
126,670$75.20$9.5M242,662(D)

View →

Mar 10, 2026Mar 11 8:18 PMKyle JenneEVP, Chf GL Pdt Str Ofcr
Sale
37,277$75.85$2.8M11,714(D)

View →

Mar 10, 2026Mar 10 8:00 PMJenne Kyle
Proposed Sale
58,253$75.57$4.4M

View →

Mar 9, 2026Mar 9 8:16 PMO'NEIL PATRICK R.
Proposed Sale
13,217$75.25$994.6K

View →

Mar 4, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Sale
200$80.00$16.0K36,330(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Sale
832$80.33$66.8K36,330(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph Klein IIIDirector
Sale
21,332$79.51$1.7M11,014(D)

View →

Mar 3, 2026Mar 5 11:14 PMAllene M. DiazDirector
Sale
54,878$79.35$4.4M3,811(D)

View →

Mar 3, 2026Mar 5 11:14 PMShannon L. DeversEVP, Chief Human Resources Ofc
Sale
20,106$79.40$1.6M22,541(D)

View →

Mar 3, 2026Mar 5 11:13 PMBENNETT C FRANKEVP, Chief Scientific Officer
Sale
85,089$79.23$6.7M80,554(D)

View →

Mar 4, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Sale
439$80.00$35.1K4,347(I)

View →

Mar 3, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Sale
6,220$79.72$495.9K4,347(I)

View →

Mar 3, 2026Mar 3 10:52 PMBENNETT C FRANK
Proposed Sale
85,089$82.93$7.1M

View →

Mar 3, 2026Mar 3 10:51 PMLOSCALZO JOSEPH
Proposed Sale
24,000$80.00$1.9M

View →

Mar 3, 2026Mar 3 10:43 PMBaroldi Mariana
Proposed Sale
8,198$80.00$655.8K

View →

Mar 3, 2026Mar 3 10:42 PMBaroldi Joseph
Proposed Sale
4,096$79.36$325.1K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 2, 2026Jan 21 1:20 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
7,500$79.6716,600(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
11,11920,830(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
24,90045,730(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
7,01329,664(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Grant/Award
35,475$0.0037,725(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Option Exercise
28,72955,940(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Grant/Award
47,245$0.0068,825(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
17,37743,029(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Grant/Award
35,475$0.0052,704(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Option Exercise
20,08941,126(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Grant/Award
35,475$0.0050,801(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
21,05517,434(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Grant/Award
35,475$0.0027,109(D)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
19,8875,474(I)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Grant/Award
39,375$0.009,374(I)

View →

← Previous

Page 3 of 3